A combination of molecular markers and clinical features improve the classification of pancreatic cysts

Springer S, Wang Y, Dal Molin M, Masica DL, Jiao Y, et al. Gastroenterology. 2015 Nov;149(6):1501-10.

Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts

Singhi AD, Nikiforova MN, Fasanella KE, McGrath KM, Pai RK, et al Clin Cancer Res. 2014 Aug 15;20(16):4381-9.

Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas

Amato E, Molin MD, Mafficini A, Yu J, Malleo G, et al. J Pathol. 2014 Jul;233(3):217-27.

Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts

Nikiforova MN, Khalid A, Fasanella KE, McGrath KM, Brand RE, et al. Mod Pathol. 2013 Nov;26(11):1478-87.

Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development

Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, et al. Sci Transl Med. 2011 Jul 20;3(92):92ra66.

Request Info